Raman & Weil Private Limited

Raman & Weil Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
CIN U24200MH1988PTC048181 Incorporated 21 July 1988 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Private Limited Company pharma MSME · Medium
Revenue · FY 2025
₹145.87 Cr
▲ 7% YoY
Net profit · FY 2025
₹14.33 Cr
Net margin 9.8%
EBITDA · FY 2025
₹22.92 Cr
EBITDA margin 15.7%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹4.26 Lakh
Issued & subscribed
Open charges
₹21.76 Cr
Satisfied ₹17.9 Cr
Company age
38 yrs
Est. 1988
Employees · EPFO
169
Provident fund records

About Raman & Weil Private Limited

Data last updated:

Raman & Weil Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 21 July 1988 and has been in existence for over 38 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24200MH1988PTC048181. Its GSTIN is 27AAACR5065M2Z0 (Maharashtra). The company holds 12 GST registrations, of which 6 are active.

The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹4.26 Lakh. It is led by directors Hiten Pravin Shah (Managing Director) and Bhowli Nikhil Shah.

Its last annual general meeting (AGM) was held on 28 July 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 36/37 3rd Floor Mittal Chamber Opp. Inox Theatre Nariman Point, Mumbai, Maharashtra, India – 400021.

As per the financials filed for FY 2025, the company reported a revenue of ₹145.87 Cr, a growth of 7% compared to the previous year. For the same year it recorded a net profit of ₹14.33 Cr (net margin 9.8%) and EBITDA of ₹22.92 Cr (EBITDA margin 15.7%). Revenue has grown at a compounded annual rate (CAGR) of 2% over three years.

The company has about 169 employees on its provident fund (EPFO) records.

As per MCA filings, the company has open charges of ₹21.76 Cr and satisfied charges of ₹17.9 Cr on record. Court records list 13 cases involving the company, including 9 filed by the company and 4 filed against it; 3 cases are pending. The company has 5 deals on record (5 secondary share transfers); the latest was in February 2024. Its 6 peer companies in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 3 larger and 3 smaller; the largest is Celon Laboratories Private Limited with revenue of ₹148.17 Cr.

Raman & Weil Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-DD-01-0001196). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website ramanweil.com.

Company details

CIN U24200MH1988PTC048181
Registration Number 048181
Incorporation Date 21 July 1988
ROC Mumbai
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-DD-01-0001196

Recognitions & Rankings of Raman & Weil

MSME (Udyam registered) Ministry of MSME
Category
Medium (2023-24)
Udyam number
UDYAM-DD-01-0001196

Contact details

Raman & Weil Private Limited's registered office is in Mumbai, Maharashtra. Its website is ramanweil.com. Its e-mail address is in the company report.

  • Email
  • Registered Address
    36/37 3rd Floor Mittal Chamber Opp. Inox Theatre Nariman Point, Mumbai, Maharashtra, India – 400021
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Raman & Weil Private Limited, buy the company report.

Comprehensive company report
Raman & Weil Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Raman & Weil is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Raman & Weil Private Limited, buy the company report.

Financials of Raman & Weil Private Limited

FY 2025 filings available

Raman & Weil Private Limited reported revenue of ₹145.87 Cr (up 7% YoY) for FY 2025.

Revenue · FY 2025
₹145.87 Cr ▲ 7%
Net profit · FY 2025
₹14.33 Cr margin 9.8%
EBITDA · FY 2025
₹22.92 Cr margin 15.7%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 7%
3 years · compounded
▲ 2%
EBITDA CAGR growth
1 year
▼ 2%
5 years · compounded
▼ 2%

Revenue has grown at a compounded annual rate (CAGR) of 2% over three years, including 7% growth in the latest year. EBITDA fell 2% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹22.92 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹14.33 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin15.7%
Net Profit Margin9.8%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Raman & Weil Private Limited, buy the company report.

Board of directors of Raman & Weil Private Limited

Raman & Weil has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Bhowli Nikhil ShahDirector21 Jul 198838 Years 3 MonthsCurrent
Hiten Pravin ShahManaging Director04 Apr 200521 Years 7 MonthsCurrent

Peer comparison

Raman & Weil Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Celon Laboratories Private Limited₹148.17 Cr (FY 2025)-7.0%Hyderabad, Telangana, India
Canton Laboratories Private Limited₹147.08 Cr (FY 2025)26.0%Vadodara, Gujarat, India
Murli Krishna Pharma Private Limited₹146.68 Cr (FY 2025)-21.0%Pune, Maharashtra, India
Raman & Weil Private Limitedthis company₹145.87 Cr (FY 2025)₹14.33 Cr9.8%7.0%Mumbai, Maharashtra, India
Pulse Pharmaceuticals Private Limited₹145.08 Cr (FY 2024)-1.0%Hyderabad, Telangana, India
Goodway Chemicals Private Limited₹144.1 Cr (FY 2025)-12.0%Mumbai, Maharashtra, India
Immacule Lifesciences Private Limited₹143.18 Cr (FY 2025)34.0%Nalagarh, Himachal Pradesh, India

To see the full peer comparison of Raman & Weil Private Limited, buy the company report.

Auditor

Raman & Weil Private Limited is audited by F K MODY & CO for the financial year 2023.

Auditor firmFinancial yearFirm registration number
F K MODY & COFY 2023115205W

Shareholding

The shareholding of Raman & Weil Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2021FY 2020FY 2019FY 2018
Promoters
Domestic institutional investors (DII)
Public
Others

To see the full shareholding pattern of Raman & Weil Private Limited, buy the company report.

Charges & borrowings

Open charges
₹21.76 Cr
Satisfied charges
₹17.9 Cr
Breakdown by lending institutions
Others₹21.76 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
06 Feb 2026101244469Others₹50 LakhOpen
28 Jan 2026101241467Others₹21 CrOpen
10 Jun 2025101129824Others₹2.62 LakhOpen
10 Jun 2025101132783Others₹21.66 LakhOpen
03 May 2025101146367Others₹1.8 LakhOpen

To see the full charge records of Raman & Weil Private Limited, buy the company report.

Total charge records: 11 View all charges

Deals & funding

Raman & Weil Private Limited has 5 deals on record (5 secondary share transfers); the latest was in February 2024.

Total deals
5
Secondary share transfers
5

Deals on record (5 of 5)

WhenDealAmountParties
Feb 2024Secondary share transferUndisclosedSeller: 4 individuals
Feb 2020Secondary share transferUndisclosedSeller: Ramanlal Finance and Investments Pvt Ltd , 2 individuals
Jan 2020Secondary share transferUndisclosedBuyer: 3 individuals
Seller: 2 individuals
May 2013Secondary share transferUndisclosedSeller: 2 individuals
Mar 2012Secondary share transferUndisclosedBuyer: an individual
Seller: an individual

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Raman & Weil Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Raman & Weil has 12 GST registrations: 6 active and 6 cancelled or inactive. The first 4 active GSTINs are listed below.

Total GSTINs
12
Active
6
Cancelled / inactive
6
GSTINStateStatusRegistered on
27AAACR5065M2Z0MaharashtraActive02 Aug 2017
27AAACR5065M3ZZMaharashtraActive01 Sep 2023
36AAACR5065M1Z2TelanganaActive01 Jul 2017
26AAACR5065M1Z3Dadra and Nagar Haveli and Daman and DiuActive01 Aug 2020

To see the full GST registrations and return filing status of Raman & Weil Private Limited, buy the company report.

Recent activity

Raman & Weil Private Limited has 6 board changes on record since 1988: 4 appointments and 2 cessations. The latest: Adimoolam Ramakrishna ceased to be Director on 01 Apr 2019.

Charges
A charge with Others amounted to Rs. 50.00 Lakh with Charge ID 101244469 was registered on 06 Feb 2026.
Charges
A charge with Others amounted to Rs. 2,100.00 Lakh with Charge ID 101241467 was registered on 28 Jan 2026.
AGM
Raman & Weil Private Limited last Annual general meeting of members was held on 28 Jul 2025 as per latest MCA records.
Charges
A charge with Others amounted to Rs. 2.62 Lakh with Charge ID 101129824 was registered on 10 Jun 2025.
Charges
A charge with Others amounted to Rs. 21.66 Lakh with Charge ID 101132783 was registered on 10 Jun 2025.
Charges
A charge with Others amounted to Rs. 1.80 Lakh with Charge ID 101146367 was registered on 03 May 2025.
Filing
Raman & Weil Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai I.
Charges
A charge registered on 12 Jul 2021 via Charge ID 100469564 with Hdfc Bank Limited was fully satisfied on 21 Nov 2024.
Charges
A charge registered on 11 Aug 2006 via Charge ID 10017074 with Citibank N.A. was fully satisfied on 09 Nov 2021.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 500.00 Lakh with Charge ID 100469564 was registered on 12 Jul 2021.
Charges
A charge registered on 11 Sep 1998 via Charge ID 80019851 with Union Bank Of India was fully satisfied on 05 Dec 2019.
Charges
A charge registered on 11 Sep 1998 via Charge ID 80020451 with Bank Of India was fully satisfied on 05 Dec 2019.

19 earlier events are in the company report.

Frequently asked questions

Raman & Weil is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 21 July 1988 (38+ years old) and is registered under CIN U24200MH1988PTC048181.

Raman & Weil has 2 current directors:

The latest financial statements of Raman & Weil on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 28 July 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Raman & Weil is 27AAACR5065M2Z0, registered in Maharashtra. The company has 12 GST registrations in all, of which 6 are active and 6 are cancelled or inactive. Other active GSTINs include 27AAACR5065M3ZZ (Maharashtra), 36AAACR5065M1Z2 (Telangana), 26AAACR5065M1Z3 (Dadra and Nagar Haveli and Daman and Diu).

The CIN (Corporate Identification Number) of Raman & Weil is U24200MH1988PTC048181. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Raman & Weil has 13 court cases on record: 9 filed by the company and 4 filed against it. 3 are pending. Most are in the high courts.

Raman & Weil was incorporated on 21 July 1988, making it 38+ years old. It is registered with the Registrar of Companies, Mumbai.

Raman & Weil has 5 deals on record (5 secondary share transfers); the latest was in February 2024.

The peers of Raman & Weil by revenue are Celon Laboratories Private Limited, Canton Laboratories Private Limited, Murli Krishna Pharma Private Limited, Pulse Pharmaceuticals Private Limited, Goodway Chemicals Private Limited and 1 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Adimoolam Ramakrishna ceased to be Director on 01 Apr 2019. Harsh Narendra Panalal ceased to be Director on 14 Dec 2016. Harsh Narendra Panalal was appointed as Director on 30 Mar 2015. Raman & Weil has 6 board changes on record in total.

Yes, Raman & Weil is registered as a medium enterprise under Udyam registration (number: UDYAM-DD-01-0001196).